{"DataElement":{"publicId":"778","version":"4","preferredName":"Prior Chemotherapy Administered Ind-3","preferredDefinition":"the yes/no indicator that asks whether the patient previously had chemotherapy as treatment for this cancer.","longName":"PRIOR_CT_ADM_IND-3","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2188711","version":"1","preferredName":"Prior Chemotherapy Administered","preferredDefinition":"information related to prior administration of chemotherapy.","longName":"PRIOR_CT_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206391","version":"1","preferredName":"Prior Chemotherapy","preferredDefinition":"Earlier in time or order.:The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)","longName":"C25629:C15632","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F3A3-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177665","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"Administered","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-516D-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E54DEB21-FF53-61DD-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506034","version":"1","preferredName":"Yes No Unknown Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.","longName":"YES_NO_UNKNOWN_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D05-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D0F-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3241403","version":"1","preferredName":"Unknown","longName":"3241403","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A3A-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"MMADDINENI","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D1A-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2548260","version":"1","preferredName":"Ind-3","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no/unknown.","longName":"C38148","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, or Unknown Response","conceptCode":"C38148","definition":"A response or indicator that can have a value of yes, no, or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"23801A33-5B13-534B-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2006-11-30","endDate":"2016-04-27","createdBy":"BIRNBAUA","dateCreated":"2006-11-30","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 4-27-2016 per Tina Taylor approved by Dianne Reeves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C379D9D0-6CF1-CCDD-E040-BB89AD432590","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TITARENI","dateModified":"2021-09-14","changeDescription":"3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 3/35/2016 jk removed \"indeterminate\" value that was added in error. 7/7/2021wz: added ALT VM name for HOPE-CARE project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"},{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"},{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"},{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"},{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"},{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"},{"publicId":"2811911","version":"1","longName":"Upper GI","context":"CTEP"},{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"},{"publicId":"10000607","version":"1","longName":"Sarcoma","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"},{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811959","version":"1","longName":"Patient Char.","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812014","version":"1","longName":"Primary Brain Recurr","context":"CTEP"},{"publicId":"2812015","version":"1","longName":"Metastatic Brain","context":"CTEP"},{"publicId":"10000028","version":"1","longName":"Bone Sarcoma Recur","context":"CTEP"},{"publicId":"2811919","version":"1","longName":"Advanced Melanoma","context":"CTEP"},{"publicId":"2811920","version":"1","longName":"Non-local Prostate","context":"CTEP"},{"publicId":"2811927","version":"1","longName":"Local-Reg Melanoma","context":"CTEP"},{"publicId":"10000311","version":"1","longName":"Met/Urothelial","context":"CTEP"},{"publicId":"2811789","version":"1","longName":"Adjuvant Esophageal","context":"CTEP"},{"publicId":"2811792","version":"1","longName":"Advanced Esophageal","context":"CTEP"},{"publicId":"10000446","version":"1","longName":"Advanced Gastric","context":"CTEP"},{"publicId":"2811810","version":"1","longName":"NSCLC 2nd Line","context":"CTEP"},{"publicId":"10000001","version":"1","longName":"NSCLC Advanced","context":"CTEP"},{"publicId":"2811821","version":"1","longName":"SCLC 2nd Line","context":"CTEP"},{"publicId":"2811822","version":"1","longName":"SCLC Extensive","context":"CTEP"},{"publicId":"2811823","version":"1","longName":"SCLC Limited","context":"CTEP"},{"publicId":"2811943","version":"1","longName":"Hodgkin's Lymphoma","context":"CTEP"},{"publicId":"2811944","version":"1","longName":"NonHodgkins Lymphoma","context":"CTEP"},{"publicId":"10000462","version":"1","longName":"Muscle Invasive Blad","context":"CTEP"},{"publicId":"2811931","version":"1","longName":"NSCLC Stage I-III","context":"CTEP"},{"publicId":"2811938","version":"1","longName":"Recurrent Gyn","context":"CTEP"},{"publicId":"10000312","version":"1","longName":"Superficial Bladder","context":"CTEP"},{"publicId":"2811885","version":"1","longName":"Adult STS Recurrent","context":"CTEP"},{"publicId":"2811889","version":"1","longName":"Ped STS Recurrent","context":"CTEP"},{"publicId":"2811904","version":"1","longName":"Multiple Myeloma","context":"CTEP"},{"publicId":"2811905","version":"1","longName":"Primary Amyloidosis","context":"CTEP"},{"publicId":"2811906","version":"1","longName":"Waldenstrom Macrogl","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2813054","version":"1","longName":"St. Joseph Hospital","context":"NCIP"}]},{"publicId":"2552643","version":"1","longName":"Training Class Examples","context":"Training","ClassificationSchemeItems":[{"publicId":"3637837","version":"1","longName":"Training","context":"Training"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"},{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"3124057","version":"1","longName":"Sarcoma Database","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3124058","version":"1","longName":"Sarcoma Database CDEs","context":"NCIP"}]},{"publicId":"3335728","version":"1","longName":"Protocols","context":"ABTC","ClassificationSchemeItems":[{"publicId":"3335732","version":"1","longName":"ABTC 0904","context":"ABTC"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104888","version":"1","longName":"GOG-0209","context":"NRG"},{"publicId":"4171051","version":"1","longName":"RTOG-1016","context":"NRG"},{"publicId":"4171052","version":"1","longName":"RTOG-0920","context":"NRG"},{"publicId":"4104933","version":"1","longName":"RTOG-1308","context":"NRG"},{"publicId":"4104935","version":"1","longName":"RTOG-1221","context":"NRG"},{"publicId":"4104937","version":"1","longName":"RTOG-1306","context":"NRG"},{"publicId":"4104883","version":"1","longName":"GOG-0240","context":"NRG"},{"publicId":"4104994","version":"1","longName":"RTOG-1201","context":"NRG"},{"publicId":"4104897","version":"1","longName":"GOG-0250","context":"NRG"},{"publicId":"4104934","version":"1","longName":"RTOG-1216","context":"NRG"},{"publicId":"10000287","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104909","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"10000288","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104899","version":"1","longName":"GOG-0261","context":"NRG"}]},{"publicId":"4254096","version":"1","longName":"Protocol Phase","context":"PBTC","ClassificationSchemeItems":[{"publicId":"10000103","version":"1","longName":"Phase I","context":"PBTC"},{"publicId":"4254119","version":"1","longName":"PBTC-042","context":"PBTC"}]}],"AlternateNames":[{"name":"0000946","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0001084","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0002529","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0058476","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0061400","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0063734","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0064943","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0065216","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0058222","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"PRIOR_CT_ADM_IND-3","type":"USED_BY","context":"CTEP"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"PRIOR_CT_ADM_IND-3","type":"USED_BY","context":"LCC"},{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"PRIOR_CT_ADM_IND-3","type":"USED_BY","context":"COG"},{"name":"PRIOR_CT_ADM_IND-3","type":"USED_BY","context":"Alliance"},{"name":"PRIOR_CT_ADM_IND-3","type":"USED_BY","context":"NRG"},{"name":"PRIOR_CT_ADM_IND_3_1","type":"OID, COG","context":"COG"}],"ReferenceDocuments":[{"name":"COMMENT_MELANOMA_72","type":"COMMENT","description":"Add instruction: If yes, provide treatment details in next module.","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Prior Chemotherapy","url":null,"context":"CTEP"},{"name":"Prior Systemic Chemotherapy","type":"Preferred Question Text","description":"Prior Systemic Chemotherapy","url":null,"context":"CTEP"},{"name":"COMMENT_BLADDER_71","type":"COMMENT","description":"Add instruction to template form: Note: If no, skip to Prior Pelvic RT below.","url":null,"context":"CTEP"},{"name":"Prior Neoadjuvant Chemotherapy","type":"Alternate Question Text","description":"Prior Neoadjuvant Chemotherapy","url":null,"context":"NCIP"},{"name":"Prior Adjuvant aChemotherapy","type":"Alternate Question Text","description":"Prior Neoadjuvant Chemotherapy","url":null,"context":"NCIP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Chemotherapy within 5 years prior to registration","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Prior systemic anti-cancer therapy","url":null,"context":"CTEP"},{"name":"LCC Text 1","type":"Alternate Question Text","description":"Other than your ongoing cancer treatment, do you have prior history of receiving chemotherapy?","url":null,"context":"LCC"},{"name":"CRF Text 6","type":"Alternate Question Text","description":"Has the patient had prior systemic chemotherapy for the study cancer?","url":null,"context":"NRG"},{"name":"COG_CRF_TEXT_1","type":"Alternate Question Text","description":"Prior Myelosuppressive Chemotherapy","url":null,"context":"COG"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Chemotherapy","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Has the patient had prior chemotherapy for another malignancy (neoadjuvant [pre-cystectomy] chemotherapy is permitted)?","url":null,"context":"NRG"},{"name":"NRG_CRF_ Text 1","type":"Alternate Question Text","description":"First-line standard systemic chemotherapy?","url":null,"context":"NRG"},{"name":"PBTC_Text3","type":"Alternate Question Text","description":"Did patient receive the last dose of known myelosuppressive anticancer chemotherapy more than 28 days prior to study enrollment?","url":null,"context":"PBTC"},{"name":"PBTC_Text4","type":"Alternate Question Text","description":"Did patient receive the last dose of known myelosuppressive anticancer therapy or immunotherapy at least 21 days prior to enrollment?","url":null,"context":"PBTC"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Did patient receive the last dose of known myelosuppressive anticancer chemotherapy at least three weeks prior to study enrollment?","url":null,"context":"PBTC"},{"name":"COG_CRF_TEXT_2","type":"Alternate Question Text","description":"Prior Non-Myelosuppressive Anti-Cancer Agents","url":null,"context":"COG"},{"name":"NRG_CRF Text 1","type":"Alternate Question Text","description":"Systemic chemotherapy for the study cancer < 3 weeks prior to start of treatment?","url":null,"context":"NRG"},{"name":"COG_CRF_TEXT_3","type":"Alternate Question Text","description":"Has patient had any prior systemic therapy?","url":null,"context":"COG"},{"name":"COG_CRF_TEXT_4","type":"Alternate Question Text","description":"Did the patient receive any anti-cancer therapy subsequent to a first protocol-defined relapse?","url":null,"context":"COG"},{"name":"NRG CRF Text 2","type":"Alternate Question Text","description":"Has the patient ever had prior systemic chemotherapy for the study cancer; or chemotherapy for a different cancer within the last 3 years?","url":null,"context":"NRG"},{"name":"NRG_CRF_TEXT3","type":"Alternate Question Text","description":"Did the patient previously have chemotherapy for the study cancer?","url":null,"context":"NRG"},{"name":"PBTC_Text2","type":"Alternate Question Text","description":"Did patient receive the last dose of known myelosuppressive anticancer therapy at least 21 days prior to enrollment?","url":null,"context":"PBTC"},{"name":"COG CRF TEXT 8","type":"Alternate Question Text","description":"Has patient received myelosuppressive chemotherapy within 2 weeks or nitrosourea within 6 weeks prior to entry onto this study?","url":null,"context":"COG"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Was the patient treated with prior systemic anticancer therapy (e.g., chemotherapy, targeted therapy, immunotherapy) within 3 years prior to entering the study?","url":null,"context":"NRG"},{"name":"CRF Text 8","type":"Alternate Question Text","description":"Does the patient have a history of systemic anti-cancer therapy (e.g., chemotherapy, targeted therapy) for MBC other than the administration of trastuzumab or lapatinib concurrently with radiation therapy for brain metastases?","url":null,"context":"CTEP"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Has patient received anti-cancer agents not known to be myelosuppressive (e.g. not associated with reduced platelet or ANC counts)?","url":null,"context":"COG"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Prior chemotherapy?","url":null,"context":"Alliance"},{"name":"CRF Text10","type":"Alternate Question Text","description":"Prior neoadjuvant chemotherapy?","url":null,"context":"Alliance"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Prior chemotherapy for this tumor","url":null,"context":"Alliance"},{"name":"COG CRF Text 11","type":"Alternate Question Text","description":"Has patient had any prior systemic therapy for the current cancer diagnosis?","url":null,"context":"COG"},{"name":"COG CRF Text 10","type":"Alternate Question Text","description":"Has the patient received myelosuppressive chemotherapy within 2 weeks or nitrosourea within 4 weeks prior to entry onto this study?","url":null,"context":"COG"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Does the patient have a history of systemic anti-cancer therapy (e.g., chemotherapy, targeted therapy) for MBC except as described in Eligibility Criterion 3.3.7?","url":null,"context":"NRG"},{"name":"COG CRF Text 12","type":"Alternate Question Text","description":"Has the patient previously had anti-cancer agents NOT known to be myelosuppressive as a treatment (e.g. not associated with reduced platelet or ANC counts)?","url":null,"context":"COG"},{"name":"COG CRF Text 13","type":"Alternate Question Text","description":"Has patient had prior Myelosuppressive Chemotherapy?","url":null,"context":"COG"},{"name":"ECOG-ACRIN - 1","type":"Alternate Question Text","description":"Prior chemotherapy in the recurrent/metastatic setting","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Has the patient previously had myelosuppressive chemotherapy as a treatment?","url":null,"context":"COG"},{"name":"COG CRF Text 14","type":"Alternate Question Text","description":"Has patient had prior therapy with a biologic agent, targeted agent, tyrosine kinase inhibitor or a metronomic non-myelosuppressive regimen?","url":null,"context":"COG"},{"name":"NRG CRF Text 3","type":"Alternate Question Text","description":"Does the participant have previous exposure to chemotherapy treatment for another cancer or due to other medical condition (e.g. methotrexate exposure for treatment of rheumatoid arthritis)?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B5EE8ACC-3F61-0ECC-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-02-05","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-02-05","modifiedBy":"TSESU","dateModified":"2023-08-11","changeDescription":"Replace VD Therapy Ind-3 2018278v2.0 with VD ID#3506034 - Yes No Unknown Indicator  - dbw","administrativeNotes":"2023.8.7 AQT added per ticket request CADSR0002698. ak 2023.8.4 AQT added per ticket request CADSR0002685. ak","unresolvedIssues":null,"deletedIndicator":"No"}}